May/June 2026 | Features
Predicting Progression to GA Using Imaging Biomarkers
Several OCT findings can help clinicians better understand a patient’s risk of progression to sight-threatening disease.
Kelly Donovan, MD, PhD, and Eleonora M. Lad, MD, PhD
May/June 2026 | Chief Medical Editors' Page
The AMD Space Race
Allen C. Ho, MD; Robert L. Avery, MD; and Lejla Vajzovic, MD
November/December 2025 | Features
Trials and Innovations in Geographic Atrophy Therapy
Novel mechanisms of action and delivery methods hold promise for patients with dry AMD.
James M. Harris, MD, PhD, and Eleonora M. Lad, MD, PhD
October 2025 | Meeting Minutes
A Peek at the 2025 Duke fAVS and AVS Courses
This year’s meetings hit it out of the park with top-notch sessions, a wet lab, and networking opportunities.
Venkatkrish M. Kasetty, MD; Yuxi Zheng, MD; Linus Shen, MD; and Angela Li, MD
April 2025 | Meeting Minutes
Key Lectures From Angiogenesis 2025
A look at top presentations and discussions ranging from imaging and therapy to the latest clinical trial data.
Catherine Manthorp, BA, Senior Editor; Alex Brodin, MA, Senior Editor; and Rebecca Hepp, MA, Editor-in-Chief
November/December 2024 | Meeting Minutes
ASRS 2024: Looking Beyond Complement Inhibition
Could the next generation of geographic atrophy therapies be born of these novel strategies?
Scott Krzywonos
March 2024 Supplement
C3 Complement Inhibition Treatment in the Real World
Eleonora Lad, MD, PhD
